Mary K. Bruno
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection 9
- Pharmacogenetics and Drug Metabolism 2
- Hepatology top 5%
- Liver physiology and pathology 6
- Liver Disease and Transplantation 2
- Biochemistry top 10%
-
- Drug Transport and Resistance Mechanisms 3
-
- Bioactive Compounds and Antitumor Agents 1
-
- Heme Oxygenase-1 and Carbon Monoxide 1
- CRISPR and Genetic Engineering 1
- Co-authors
- Steven D. CohenStęphan T. SternEdward A. KhairallahJeroen ButersJerrold M. WardFrank J. GonzalezHani ZaherAngela M. Lucas
- Cited by
- PharmacologyHepatologyBiochemistry
- Journals
- Biochemical Pharmacology (2 papers)Toxicology and Applied Pharmacology (6 papers)Advances in experimental medicine and biology (1 paper)
- Partner nations
- United States
In The Last Decade
Mary K. Bruno
12 papers receiving 724 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 585
- Hepatology 186
- Biochemistry 61
- Oncology 212
- Emergency Medicine 43
Countries citing papers authored by Mary K. Bruno
This map shows the geographic impact of Mary K. Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary K. Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary K. Bruno more than expected).
Fields of papers citing papers by Mary K. Bruno
This network shows the impact of papers produced by Mary K. Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary K. Bruno. The network helps show where Mary K. Bruno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary K. Bruno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 9 | |
| 2 | 2004 | 24 | |
| 3 | 2004 | 49 | |
| 4 | Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10. | 2002 | 128 |
| 5 | 2002 | 101 | |
| 6 | 1998 | 262 | |
| 7 | 1992 | 8 | |
| 8 | 1992 | 71 | |
| 9 | 1991 | 1 | |
| 10 | 1990 | 8 | |
| 11 | 1988 | 37 | |
| 12 | 1988 | 45 |
About Mary K. Bruno
Mary K. Bruno is a scholar working on Pharmacology, Hepatology and Toxicology, having authored 12 papers that have together received 743 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (9 papers), Liver physiology and pathology (6 papers), Drug Transport and Resistance Mechanisms (3 papers), Liver Disease and Transplantation (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Heme Oxygenase-1 and Carbon Monoxide (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Pharmacology (585 citations), Hepatology (186 citations) and Biochemistry (61 citations). Mary K. Bruno has collaborated with scholars based in United States. Frequent co-authors include Steven D. Cohen, Stęphan T. Stern, Edward A. Khairallah, Jeroen Buters, Jerrold M. Ward, Frank J. Gonzalez, Hani Zaher, Angela M. Lucas, Donna M. Dambach and Jeffrey D. Laskin. Their work appears in journals such as Biochemical Pharmacology, Toxicology and Applied Pharmacology and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.